Literature DB >> 10773596

Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.

T Steiniche1, P Christiansen, A Vesterby, R Ullerup, I Hessov, L E Mosekilde, F Melsen.   

Abstract

In 19 patients with primary hyperparathyroidism (PHPT) (14 women and 5 men; age 53 +/- 11 years, range 29-69 years), bone densitometry, biochemical markers of bone turnover, and iliac crest bone biopsies were obtained before and 3 years after successful surgical treatment. A significant increase in bone mineral content (BMC) was observed in both the lumbar spine (p < 0.001) and the proximal part of the distal forearm (p < 0.001), whereas the increase in BMC in the femoral neck was insignificant. Biochemical markers of bone formation (serum alkaline phosphatase, serum bone alkaline phosphatase and serum osteocalcin) and resorption (serum pyridinoline cross-linked telopeptide of type I collagen and urine N-telopeptide of type I collagen) all decreased following treatment. In cortical bone, relative cortical width increased following surgery (p < 0.05) and cortical porosity decreased (p < 0.01). No changes were observed in core width or cortical width. In cancellous bone, no significant changes were observed in any of the measured structural parameters. However, significant reductions in the extent of osteoid- (p < 0.01) and tetracycline-labeled surfaces (p < 0.001), and in bone formation rate (p < 0.001) and activation frequency (p < 0.001), were found. The numerical decrease in the extent of eroded surfaces did not reach significance (p = 0.057). No changes were observed in mineral appositional rate and adjusted appositional rate. The amount of bone resorbed (expressed as the resorption depth) and the amount of bone reformed (expressed as wall thickness) per remodeling cycle seemed unaffected by the treatment. Consequently, no effect on bone balance per remodeling cycle could be detected. The present study of PHPT patients showed that, within 3 years after surgery, BMC of both cancellous and cortical bone areas had increased. At the same time, bone turnover decreased markedly, as judged from biochemical as well as histomorphometric data, but no changes were seen in trabecular bone structure. In cortical bone, the relative cortical width increased and the cortical porosity decreased.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773596     DOI: 10.1016/S8756-3282(00)00260-X

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  16 in total

1.  Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels.

Authors:  L L Rødbro; L S Bislev; T Sikjær; L Rejnmark
Journal:  Osteoporos Int       Date:  2018-06-28       Impact factor: 4.507

Review 2.  Bone turnover in hyperparathyroidism.

Authors:  Katharina Kerschan-Schindl
Journal:  Wien Med Wochenschr       Date:  2012-07-18

3.  Changes in bone turnover markers in primary hyperparathyroidism and response to surgery.

Authors:  P Rajeev; A Movseysan; A Baharani
Journal:  Ann R Coll Surg Engl       Date:  2017-09       Impact factor: 1.891

4.  Method for cortical bone structural analysis from magnetic resonance images.

Authors:  Bryon R Gomberg; Punam K Saha; Felix W Wehrli
Journal:  Acad Radiol       Date:  2005-10       Impact factor: 3.173

Review 5.  Bone Involvement in Primary Hyperparathyroidism and Changes After Parathyroidectomy.

Authors:  Lars Rolighed; Lars Rejnmark; Peer Christiansen
Journal:  Eur Endocrinol       Date:  2014-02-28

6.  Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy.

Authors:  Philippe Boudou; Fidaa Ibrahim; Catherine Cormier; Emile Sarfati; Jean-Claude Souberbielle
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

7.  Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism.

Authors:  D W Dempster; R Müller; H Zhou; T Kohler; E Shane; M Parisien; S J Silverberg; J P Bilezikian
Journal:  Bone       Date:  2007-04-11       Impact factor: 4.398

8.  Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.

Authors:  Masanobu Ohishi; Riccardo Chiusaroli; Michael Ominsky; Frank Asuncion; Clare Thomas; Richa Khatri; Paul Kostenuik; Ernestina Schipani
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

Review 9.  Bone turnover markers in primary hyperparathyroidism.

Authors:  Aline G Costa; John P Bilezikian
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

10.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.